| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/02/1998 | WO1998013052A1 Anti-allergic and anti-inflammatory product, method for producing the same, cosmetic product and hygienic product |
| 04/02/1998 | WO1998013029A1 Oral delayed immediate release formulation and method of preparation therefor |
| 04/02/1998 | WO1998012910A2 NOVEL CREBa ISOFORM |
| 04/02/1998 | DE19638313A1 Composition containing immunomodulatory peptide or protein and adjuvant |
| 04/02/1998 | CA2266427A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 04/02/1998 | CA2266315A1 Method of preventing acute rejection following solid organ transplantation |
| 04/02/1998 | CA2265554A1 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales |
| 04/02/1998 | CA2264544A1 Snrnp sm proteins |
| 04/02/1998 | CA2236154A1 Novel creba isoform |
| 04/01/1998 | EP0832978A2 Novel 3-dehydroquinate synthase |
| 04/01/1998 | EP0832977A2 Novel sugar kinase |
| 04/01/1998 | EP0832975A2 Histidinol dehydrogenase from Staphylococcus aureus |
| 04/01/1998 | EP0832973A2 GTP-binding protein |
| 04/01/1998 | EP0832901A1 Antibodies to hepatitis G virus, and their diagnostic use to detect HGV, and as therapeutic agent |
| 04/01/1998 | EP0832289A1 Novel gene-up regulated in regenerating liver |
| 04/01/1998 | EP0832265A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 04/01/1998 | EP0832255A1 Recombinant bacterial system with environmentally limited viability |
| 04/01/1998 | EP0832253A2 Nucleic acid respiratory syncytial virus vaccines |
| 04/01/1998 | EP0832252A1 Use of gram-positive bacteria to express recombinant proteins |
| 04/01/1998 | EP0832249A2 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 04/01/1998 | EP0832242A1 Neutralizing conformational epitopes of chicken anemia virus |
| 04/01/1998 | EP0832241A1 Mutants of streptococcal toxin a and methods of use |
| 04/01/1998 | EP0832239A1 Camp factor of streptococcus uberis |
| 04/01/1998 | EP0832238A1 Streptococcal heat shock proteins members of the hsp70 family |
| 04/01/1998 | EP0832237A1 Isospora suis vaccine |
| 04/01/1998 | EP0832236A1 Methods for enhancement of protective immune responses |
| 04/01/1998 | EP0832231A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR |
| 04/01/1998 | EP0832225A1 Chimeric proteins for use in transport of a selected substance into cells |
| 04/01/1998 | EP0832224A1 Hepatocyte growth factor receptor antagonists and uses thereof |
| 04/01/1998 | EP0832223A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION |
| 04/01/1998 | EP0832216A1 Fibroblast growth factor 15 |
| 04/01/1998 | EP0832215A1 Fibroblast growth factor 11 |
| 04/01/1998 | EP0832197A1 Recombinant fowlpox viruses and uses thereof |
| 04/01/1998 | EP0832185A1 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods |
| 04/01/1998 | EP0832135A1 THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-Fc RECEPTOR ANTIBODIES |
| 04/01/1998 | EP0832134A1 Anti-allergy bispecific molecules |
| 04/01/1998 | EP0832128A2 Thrombin receptor homolog |
| 04/01/1998 | EP0832127A2 Synthetic peptides and pharmaceutical compositions comprising them |
| 04/01/1998 | EP0832126A1 G-protein receptor htnad29 |
| 04/01/1998 | EP0832118A2 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 04/01/1998 | EP0832117A1 Ligand-stimulated gene expression |
| 04/01/1998 | EP0832114A2 Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus |
| 04/01/1998 | EP0832112A1 Monocyte chemotactic protein-4 |
| 04/01/1998 | EP0832109A1 Fibroblast growth factor homologous factor-2 and methods of use |
| 04/01/1998 | EP0832107A1 An improved peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone lhrh, and analogs of the lhrh tandem repeat peptide and their use as vaccine |
| 04/01/1998 | EP0832093A1 Expression of lipoproteins |
| 04/01/1998 | EP0831940A1 Hiv-1 prophylactic composition and method |
| 04/01/1998 | EP0831937A1 Immunological combination compositions and methods |
| 04/01/1998 | EP0831925A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 04/01/1998 | EP0831921A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 04/01/1998 | EP0831917A2 Immunotoxins specific for cd80 and cd86 expressing cells |
| 04/01/1998 | EP0831906A1 Treatment of t cell mediated autoimmune disorders |
| 04/01/1998 | EP0831905A1 Methods of treating colon cancer utilizing tumor-specific antibodies |
| 04/01/1998 | EP0831904A1 Treatment and diagnosis of prostate cancer |
| 04/01/1998 | EP0831903A1 Connective tissue growth factor |
| 04/01/1998 | EP0831901A1 Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein |
| 04/01/1998 | EP0831900A1 Methods of raising antibodies against e.coli of the family cs4-cfa/1 |
| 04/01/1998 | EP0831899A1 Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (rhdv)] compositions and uses |
| 04/01/1998 | EP0831898A1 Modified meningococcal polysaccharide conjugate vaccines |
| 04/01/1998 | EP0831897A1 In ovo vaccination against coccidiosis |
| 04/01/1998 | EP0831896A1 In ovo vaccination against coccidiosis |
| 04/01/1998 | EP0831895A1 Tumor associated epitopes |
| 04/01/1998 | EP0831894A1 Immunogenic and immunostimulatory oligosaccharide compositions and methods of making and using them |
| 04/01/1998 | EP0831892A1 Multimeric, recombinant urease vaccine |
| 04/01/1998 | EP0831885A1 Methods and uses of connective tissue growth factor as an induction agent |
| 04/01/1998 | EP0831881A1 Method for increasing hdl cholesterol level |
| 04/01/1998 | EP0831880A1 Antibody and antibody fragments for inhibiting the growth of tumors |
| 04/01/1998 | EP0831875A1 Methods of inhibiting phagocytosis |
| 04/01/1998 | EP0831860A1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation |
| 04/01/1998 | EP0831790A2 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby |
| 04/01/1998 | EP0831780A1 Improved liposomal formulation |
| 04/01/1998 | EP0831779A1 Process for making liposome preparation |
| 04/01/1998 | EP0831718A1 High moisture nutrient formulation for poultry and other animals |
| 04/01/1998 | EP0573510B1 Anti-growth factor antibodies in the treatment of vascular stenosis |
| 04/01/1998 | EP0466838B1 Novel lipid a derivatives and uses therefor |
| 04/01/1998 | CN1177982A System for the expression of heterologous antigens as fusion proteins |
| 04/01/1998 | CN1177980A Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis |
| 03/31/1998 | US5734035 Nematode vaccine |
| 03/31/1998 | US5734019 Hepatitis C virus antigen polypeptide, production method therefor, and antibody detection method |
| 03/31/1998 | US5733933 Methods and materials for the diagnosis and treatment of conditions such as stroke |
| 03/31/1998 | US5733780 Construction of Pasteurella haemolytica vaccines |
| 03/31/1998 | US5733778 Vaccines, medical diagnosis |
| 03/31/1998 | US5733772 Cloning and expression of Plasmodium falciparum transmission blocking target antigen, Pfs230 |
| 03/31/1998 | US5733748 Isolated polynucleotide; cancer diagnosis |
| 03/31/1998 | US5733745 Pure genetic engineered protein |
| 03/31/1998 | US5733742 Polyclonal immunoglobulin fab fragments |
| 03/31/1998 | US5733740 Taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
| 03/31/1998 | US5733600 Method and apparatus for preparing sample cartridges for a particle acceleration device |
| 03/31/1998 | US5733556 Newcastle disease virus combination vaccine |
| 03/31/1998 | US5733555 Live bovine syncytial virus |
| 03/31/1998 | US5733554 Avian herpesvirus-based live recombinant avian vaccine, in particular against Gumboro disease |
| 03/31/1998 | US5733550 Method for enhancing the association of exogenous peptides with class I MHC molecules on the surface of antigen presenting cells with β-microglobulin |
| 03/31/1998 | US5733548 Stimulating t-cell response |
| 03/31/1998 | US5733547 Treatment of autoimmune arthritis by oral administration of type I or type III collagen |
| 03/31/1998 | US5733546 Immunochemical detection of in vivo advanced glycosylation endproducts |
| 03/31/1998 | US5733524 Screening for neuroprotective agents by administering them with infarct-producing amine compounds, then comparing responses in treated and untreated animals |
| 03/31/1998 | CA2040441C Fusion proteins |
| 03/31/1998 | CA1339792C Purification of hepatitis proteins |
| 03/26/1998 | WO1998012562A1 Adhesins from heliobacter pylori and their diagnostic and therapeutic uses |
| 03/26/1998 | WO1998012334A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |